Effects of thymosin - α1 on cell immunity function in patients with septic shock

Chinese Critical Care Medicine

Volumn 19, Issue 3, 2007, Pages 153-155

  Chen, Jiang ^a  

^a Changshan People's Hospital   (China)

Author keywords

Natural killer cell; Septic shock; T lymphocyte subtype; Thymosin 1

Indexed keywords

ANTIBIOTIC AGENT; CD3 ANTIGEN; CD4 ANTIGEN; THYMOSIN ALPHA1; DRUG DERIVATIVE; IMMUNOLOGICAL ADJUVANT; THYMOSIN;

ARTICLE; CD4 CD8 RATIO; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; IMMUNOMODULATION; LYMPHOCYTE COUNT; NATURAL KILLER CELL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEPTIC SHOCK; T LYMPHOCYTE; ADULT; AGED; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; T LYMPHOCYTE SUBPOPULATION;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; PROGNOSIS; SHOCK, SEPTIC; T-LYMPHOCYTE SUBSETS; THYMOSIN;

EID: 34047195992     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chinese source.
2. Levy M M, Fink M P, Marshall J C, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference [J]. Crit Care Med, 2003, 31(4):1250-1256.
3. Chinese source.
4. Chinese source.
5. Chinese source.
6. Adrie C, Pinsky M R. The inflammatory balance in human sepsis [J]. Intensive Care Med, 2000, 26(4):364-375.
7. Martin C, Boisson C, Haccoun M, et al. Patterns of cytokine evolution (tumor necrosis factor - alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma[J]. Crit Care Med, 1997, 25(11):1813-1819.
8. Hotchkiss R S, Tinsley K W, Karl I E. Role of apoptotic cell death in sepsis[J]. Scand J Infect Dis, 2003, 35(9):585-592.
9. Chinese source.
10. Chien R N, Liaw Y F, Chen T C, et al. Efficacy of thymosin alpha 1 in patients with chronic hepatitis B: a randomized, controlled trial [J]. Hepatology, 1998, 27(5):1383-1387.
11. Moscarella S, Buzzelli G, Romanelli R G, et al. Interferon and thymosin combination therapy in naive patients with chronic hepatitis C:preliminary results [J]. Liver, 1998, 18(5):366-369.
12. Garaci E, Pica F, Rasi G, et al. Combination therapy with BRMs in cancer and infectious diseases [J]. Mech Ageing Dev, 1997, 96 (1-3):103-116.